VEON Ltd. [NASDAQ: VEON] plunged by -$0.04 during the normal trading session on Wednesday and reaching a high of $1.75 during the day while it closed the day at $1.68. The company report on January 5, 2022 that Karen Linehan joins the VEON Board as a non-executive Director.
VEON Ltd. (NASDAQ: VEON) (Euronext Amsterdam: VEON), a leading global provider of connectivity and internet services, today announced that Karen Linehan, former General Counsel of Sanofi, has joined the VEON Board as a non-executive director.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Karen spent more than 30 years at Sanofi, a leading international healthcare company, in different legal roles, including more than a decade as General Counsel, leading the Legal, Ethics and Business Integrity function. With her global team, she effectively safeguarded the company and its stakeholders from the many challenges of the pharmaceutical sector’s rapidly evolving environment.
VEON Ltd. stock has also loss -0.59% of its value over the past 7 days. However, VEON stock has declined by -24.66% in the 3 months of the year. Over the past six months meanwhile, it has lost -11.58% and lost -1.75% year-on date.
The market cap for VEON stock reached $2.95 billion, with 1.75 billion shares outstanding and 907.90 million shares in the current float. Compared to the average trading volume of 4.57M shares, VEON reached a trading volume of 7287377 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about VEON Ltd. [VEON]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VEON shares is $2.71 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VEON stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BofA Securities have made an estimate for VEON Ltd. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 26, 2021. The new note on the price target was released on January 27, 2021, representing the official price target for VEON Ltd. stock.
The Average True Range (ATR) for VEON Ltd. is set at 0.07, with the Price to Sales ratio for VEON stock in the period of the last 12 months amounting to 0.38. The Price to Book ratio for the last quarter was 7.64, with the Price to Cash per share for the same quarter was set at 0.87. Price to Free Cash Flow for VEON in the course of the last twelve months was 4.23 with Quick ratio for the last quarter at 0.60.
VEON stock trade performance evaluation
VEON Ltd. [VEON] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.59. With this latest performance, VEON shares dropped by -3.45% in over the last four-week period, additionally sinking by -11.58% over the last 6 months – not to mention a rise of 1.82% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VEON stock in for the last two-week period is set at 41.06, with the RSI for the last a single of trading hit 42.17, and the three-weeks RSI is set at 40.39 for VEON Ltd. [VEON]. The present Moving Average for the last 50 days of trading for this stock 1.8356, while it was recorded at 1.7100 for the last single week of trading, and 1.8721 for the last 200 days.
VEON Ltd. [VEON]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and VEON Ltd. [VEON] shares currently have an operating margin of +19.17 and a Gross Margin at +52.27. VEON Ltd.’s Net Margin is presently recorded at -4.37.
Return on Total Capital for VEON is now 13.26, given the latest momentum, and Return on Invested Capital for the company is -3.99. Return on Equity for this stock declined to -49.97, with Return on Assets sitting at -2.34. When it comes to the capital structure of this company, VEON Ltd. [VEON] has a Total Debt to Total Equity ratio set at 6,169.33. Additionally, VEON Total Debt to Total Capital is recorded at 98.40, with Total Debt to Total Assets ending up at 69.11. Long-Term Debt to Equity for the company is recorded at 5,418.40, with the Long-Term Debt to Total Capital now at 86.43.
Reflecting on the efficiency of the workforce at the company, VEON Ltd. [VEON] managed to generate an average of -$7,015 per employee. Receivables Turnover for the company is 10.21 with a Total Asset Turnover recorded at a value of 0.53.VEON Ltd.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 0.60.
VEON Ltd. [VEON]: Insider Ownership positions
There are presently around $714 million, or 28.70% of VEON stock, in the hands of institutional investors. The top three institutional holders of VEON stocks are: EXOR CAPITAL LLP with ownership of 78,347,333, which is approximately 0% of the company’s market cap and around 39.60% of the total institutional ownership; MORGAN STANLEY, holding 56,943,201 shares of the stock with an approximate value of $97.94 million in VEON stocks shares; and TT INTERNATIONAL, currently with $77.25 million in VEON stock with ownership of nearly 8.589% of the company’s market capitalization.
Positions in VEON Ltd. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 63 institutional holders increased their position in VEON Ltd. [NASDAQ:VEON] by around 60,657,762 shares. Additionally, 42 investors decreased positions by around 16,854,073 shares, while 22 investors held positions by with 337,527,217 shares. The mentioned changes placed institutional holdings at 415,039,052 shares, according to the latest SEC report filing. VEON stock had 11 new institutional investments in for a total of 19,488,804 shares, while 8 institutional investors sold positions of 830,009 shares during the same period.